Vascular Graft Market Size, Share, Trends, Growth and Forecast 2032

Report Overview

The global Vascular Graft Market size was worth around USD 1958.98 Million in 2023 and is predicted to grow to around USD 3,571.32 Million by 2032 with a compound annual growth rate (CAGR) of roughly 6.90% between 2024 and 2032.

Request Free Sample

The study includes drivers and restraints for the vascular graft market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the vascular graft market on a global level. Key factors driving the market growth include the increasing number of dialysis procedures and rising chronic kidney disease (CKD) cases globally. Worldwide, over 2 million people receive treatment for dialysis. Around 37 million people in the U.S. and 3 million people are estimated to suffer from CKD. Moreover, the prevalence of cardiovascular diseases, diabetes, and end-stage renal disease is also expected to drive the market. Cardiovascular disease (CVD) is the leading cause of death in the U.S. and according to the data published by World Health Organization, an estimated 17.9 million people died due to CVD in 2019.

Vascular bypass grafting is a surgical procedure performed for ischemic heart disease and peripheral vascular disease. The vascular graft is a medical device that acts as an artificial blood vessel. They are implanted in patients with blocked blood vessels to redirect the flow of blood from one area to another. It also restores the normal flow of blood within the body. Porosity in vascular graft allows scaffold to rebuild perivascular tissue. Vascular surgeries are performed to repair arterial stenosis, aneurysms, and unwanted blood clots. Several bioactive substances have been integrated into synthetic grafts by means of various delivery methods to modulate graft healing procedure. One such example includes fibrin glue (FG) delivery of growth factors into ePTFE grafts. Major factors driving vascular graft market include increasing prevalence of cardiovascular diseases, diabetes and last stage of renal diseases, cardiac aneurysms, coronary artery disease (CAD) and hypertension.

Cardiovascular diseases (CVD) may cause vascular occlusion, patients with aneurysms require repair, and also those undertaking hemodialysis to manage kidney failure, undergo prosthetic vascular graft implant. In Europe, around 4.35 million deaths attributed due to cardiovascular disease (CVD) every year, and over 48 million adults in the region live with diabetes, which will increase the risk of cardiovascular disease, and it is the most common cause of kidney failure. Other factors driving vascular graft market growth include genetic and hereditary factors, unhealthy lifestyles such as tobacco smoking and excess alcohol consumption may give rise to various chronic diseases. However, low reimbursement and increasing Out-of-Pocket expenses in developing countries may hinder industry growth.

Request Free Sample

Global Vascular Graft  Market Size: Growth Factors

In order to give the users of this report a comprehensive view on the vascular graft market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product segment, raw material segment, portability segment, application segment and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new raw material launch, agreements, partnerships, collaborations & joint ventures, research & development, raw material and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

Vascular Graft  Market: Report Scope

Segments Covered in the Report

The study provides a decisive view on the vascular graft market by segmenting the market based on product, raw material, end user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2023.

Based on the product the market is segmented into hemodialysis access graft, endovascular stent graft, peripheral vascular and coronary artery by-pass graft.

Based on the raw material the market is segmented as polyester, Polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic.

Based on end users the market is segmented into hospitals, ambulatory surgery center, and others category.

Regional Insights

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S., U.K., Germany, France, China, Japan, India, Brazil, and Middle East and Africa. This segmentation includes demand for vascular graft market based on product, raw material and end users in all the regions and countries. 

North America held a major revenue share of the global vascular graft market in 2017 and the region is anticipated to continue with its regional supremacy over the forecast period. The growth of this regional market is attributed due to the high expenditure on healthcare, the presence of major industry players in the region and increased funding for research and development activities. Asia-Pacific is projected to grow at a significant growth rate, due to the high prevalence of chronic diseases such as cardiovascular disease and diabetes that will demand for vascular grafts.Key Companies and & Market Share Insights

Partnerships, collaborations, mergers & acquisitions, and the development of new products are the key strategies adopted by key players operating in the market to gain a competitive edge in the market. For instance, in November 2019, Terumo Corporation announced the acquisition of Aortic Corporation. The acquisition aided the growth of the company’s vascular grafts business segment and contributed toward personalized aortic therapy.

Some of the key players in the vascular graft market include Artegraft, B. Braun Melsungen, C.R. Bard, Cook Medical, CryoLife, Heart Medical Europe BV, LeMaitre Vascular, MAQUET Holding, Medtronic, Shanghai Suokang Medical Implants, Vascular Grafts Solutions and others. Industry players majorly focus on new product development and long-term agreements in order to gain maximum share in the market.

The report also includes detailed profiles of end players such as -

• Artegraft
• B. Braun Melsungen
• C.R. Bard
• Cook Medical
• CryoLife
• Heart Medical Europe BV
• LeMaitre Vascular
• MAQUET Holding
• Medtronic
• Shanghai Suokang Medical Implants
• Vascular Grafts Solutions and others  

This report segments the global vascular graft market as follows:

Global Vascular Graft Market: Product Segment Analysis

• Hemodialysis Access Graft
• Endovascular Stent Graft
• Peripheral vascular
• Coronary Artery Bypass Graft 

Global Vascular Graft Market: Raw Material Segment Analysis

• Polyester
• Polytetrafluoroethylene (PTFE)
• Polyurethane
• Biosynthetic  

Global Vascular Graft Market: End-User Segment Analysis

• Hospitals
• Ambulatory Surgery Center
• Others  

Global Vascular Graft Market: Regional Segment Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa